Glaxosmithkline Pharmaceuticals has informed that Abhinav Kashyap - Pharma Technology Lead, has tendered his resignation effective from the close of business hours on 31st December 2023 to pursue other opportunities outside of the Company. As a result, he will also cease to be a Senior Management Personnel of the Company. The Company places on record appreciation for his contributions during his tenure with the Company. The copy of his resignation email is enclosed. Further, the information required in terms of Regulation 30 read with Schedule Ill - Para A (7) of Part A of the SEBI Listing Regulations and SEBI Circular bearing Ref. No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July, 2023 is enclosed as ‘Annexure-I’ to this letter.
The above information is a part of company’s filings submitted to BSE.
